Shima M - Search Results

1

Factor (F)VIII/VIIa enhances global haemostatic function in the co-presence of bypassing agents and FVIII among patients with haemophilia A with inhibitor.

Nogami K, Matsumoto T, Yada K, Ogiwara K, Furukawa S, Shida Y, Takeyama M, Shima M. Nogami K, et al. Among authors: shima m. Br J Haematol. 2018 May;181(4):528-536. doi: 10.1111/bjh.15209. Epub 2018 Apr 2. Br J Haematol. 2018. PMID: 29611182 Free article.

2

A monoclonal antibody (NMC-VIII/10) to factor VIII light chain recognizing Glu1675-Glu1684 inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells.

Shima M, Yoshioka A, Nakajima M, Nakai H, Fukui H. Shima M, et al. Br J Haematol. 1992 Aug;81(4):533-8. doi: 10.1111/j.1365-2141.1992.tb02988.x. Br J Haematol. 1992. PMID: 1390241

3

Changes in polypeptide-specific factor VIII antigen levels during whole blood clotting.

Tanaka I, Yoshioka A, Shima M, Fujiwara T, Terada S, Nakai H, Sawamoto Y, Kamisue S, Fukui H. Tanaka I, et al. Among authors: shima m. Int J Hematol. 1991 Dec;54(6):523-30. Int J Hematol. 1991. PMID: 1724392

4

Clinical evaluation of recombinant human factor VIII (BAY w 6240) in the treatment of hemophilia A.

Fukui H, Yoshioka A, Shima M, Tanaka I, Koshihara K, Fukutake K, Fujimaki M. Fukui H, et al. Among authors: shima m. Int J Hematol. 1991 Oct;54(5):419-27. Int J Hematol. 1991. PMID: 1756252 Clinical Trial.

5

Factor VIII polypeptide specificity of monoclonal anti-factor VIII antibodies.

Shima M, Yoshioka A, Nakai H, Tanaka I, Fujiwara T, Terada S, Imai S, Fukui H. Shima M, et al. Br J Haematol. 1988 Sep;70(1):63-9. doi: 10.1111/j.1365-2141.1988.tb02435.x. Br J Haematol. 1988. PMID: 3140888

6

The use of porcine factor VIII in Japan.

Yoshioka A, Shima M, Morichika S, Terada S, Fukui H. Yoshioka A, et al. Among authors: shima m. Semin Hematol. 1994 Apr;31(2 Suppl 4):26-8. Semin Hematol. 1994. PMID: 7939769 Clinical Trial. No abstract available.

7

Abnormal factor VIII Hiroshima: defect in crucial proteolytic cleavage by thrombin at Arg1689 detected by a novel ELISA.

Kamisue S, Shima M, Nishimura T, Tanaka I, Nakai H, Morichika S, Takata N, Kuramoto A, Yoshioka A. Kamisue S, et al. Among authors: shima m. Br J Haematol. 1994 Jan;86(1):106-11. doi: 10.1111/j.1365-2141.1994.tb03259.x. Br J Haematol. 1994. PMID: 8011517

8

Common inhibitory effects of human anti-C2 domain inhibitor alloantibodies on factor VIII binding to von Willebrand factor.

Shima M, Nakai H, Scandella D, Tanaka I, Sawamoto Y, Kamisue S, Morichika S, Murakami T, Yoshioka A. Shima M, et al. Br J Haematol. 1995 Nov;91(3):714-21. doi: 10.1111/j.1365-2141.1995.tb05374.x. Br J Haematol. 1995. PMID: 8555081

9

Thrombelastgram as a hemostatic monitor during recombinant factor VIIa treatment in hemophilia A patients with inhibitor to factor VIII.

Yoshioka A, Nishio K, Shima M. Yoshioka A, et al. Among authors: shima m. Haemostasis. 1996;26 Suppl 1:139-42. doi: 10.1159/000217256. Haemostasis. 1996. PMID: 8904189

10

[Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].

Shima M, Sawamoto Y, Kamisue M, Shibata Y, Tuzi S, Kuwabara M, Tanaka I, Tanizawa T, Tanaka A, Ueda M, Kakishita E, Yoshioka A. Shima M, et al. Rinsho Ketsueki. 1996 Nov;37(11):1303-8. Rinsho Ketsueki. 1996. PMID: 8960666 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

922 results

Search Page

Filters